A group of experts from the Centers for Disease Control and Prevention (the United States Centers for Disease Control and Prevention) deems it necessary to have further data and has thus postponed the decision on the resumption of vaccinations with Johnson & Johnson after the precautionary stop of the authorities US regulations following the rare cases of thrombosis in six women.
The US suspends the Johnson & Johnson vaccine as a precaution: “Extremely rare adverse events”
by our correspondent Federico Rampini
The experts will meet within 7-10 days, according to US media. Some FDA scientists had instead argued that the risks could be mitigated with adequate warnings.
The United States Vaccination Advisory Committee reviewed the clinical data of six women aged 18 to 48 who developed thrombosis two weeks after vaccination. However, the federal government has already made it known that the suspension of the J&J serum will not have repercussions on the current vaccination campaign.
.